Quick Answer: GHRP-2, GHRP-6, hexarelin, and ipamorelin are all synthetic GHS-R1a agonists that stimulate pulsatile growth hormone secretion, but they differ substantially in potency, receptor selectivity, cortisol co-stimulation, and secondary tissue effects differences that determine which compound researchers select for a given model
They are not subject to the same rigorous clinical trial requirements and manufacturing oversight as FDA-approved drugs
This has to be working." But your body is doing math your brain isn't
The two drugs are used in different ways, but each has its own advantages
Mean Changes in Anthropometry and Cardiometabolic Parameters at Week 104 in Study 11,2 1Parameters listed in the table were not included in the pre-specified hierarchical testing
This can occur by trafficking-mediated alterations in the signalling of integrins to Rho GTPases and by the ability of integrins to control the trafficking of receptor tyrosine kinases, such as vascular endothelial growth factor receptor 2 and epidermal growth factor 1
